ERF and craniosynostosis: The treatment of animals with compounds that can enhance Erf nuclear accumulation and repressor function, and analysis of skulls by microcomputed tomography (microCT), support the validity of the functional augmentation hypothesis and suggest that Erf can be a viable pharmacological target in craniosynostosis.